Stock Analysis

Noratis Full Year 2023 Earnings: Revenues Beat Expectations

XTRA:NUVA
Source: Shutterstock

Noratis (ETR:NUVA) Full Year 2023 Results

Key Financial Results

  • Revenue: €60.8m (down 29% from FY 2022).
  • Net loss: €10.9m (down by 233% from €8.23m profit in FY 2022).
earnings-and-revenue-growth
XTRA:NUVA Earnings and Revenue Growth May 30th 2024

All figures shown in the chart above are for the trailing 12 month (TTM) period

Noratis Revenues Beat Expectations

Revenue exceeded analyst estimates by 9.2%.

Looking ahead, revenue is forecast to grow 14% p.a. on average during the next 3 years, compared to a 17% decline forecast for the Real Estate industry in Germany.

Performance of the German Real Estate industry.

The company's share price is broadly unchanged from a week ago.

Risk Analysis

Be aware that Noratis is showing 2 warning signs in our investment analysis that you should know about...

Valuation is complex, but we're helping make it simple.

Find out whether Noratis is potentially over or undervalued by checking out our comprehensive analysis, which includes fair value estimates, risks and warnings, dividends, insider transactions and financial health.

View the Free Analysis

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.